Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Feb. 28, 2019 |
Feb. 28, 2018 |
Feb. 28, 2017 |
|
| Sales tax receivables | $ 82,992 | $ 177,903 | |
| Reduction of research and development expenses | 305,592 | 221,202 | $ 148,547 |
| Research and development tax credits received | 0 | 0 | 88,080 |
| Research and development tax credits receivable | 410,997 | 109,298 | |
| Government grants received | 73,581 | 4,000 | 0 |
| Government grants receivable | 0 | 73,581 | 0 |
| Non-cash research and development tax credits | 255,975 | 248,690 | 25,227 |
| Research and development expense | $ 3,448,547 | $ 6,694,778 | $ 1,454,440 |
| Stock Options | |||
| Dilutive securities | 1,962,400 | 2,374,581 | 1,010,000 |
| Restricted Stock Units | |||
| Dilutive securities | 402,868 | 34,102 | 0 |
| Warrants | |||
| Dilutive securities | 802,469 | 140,667 | 637,670 |